ALEC 8-K 2026-10-05
Alector, Inc. (ALEC) 8-K dated 2026-10-05 — accession 0001193125-26-413090.
Alector, Inc. (ALEC) is a biotechnology company listed on US.
ALEC to acquire platform ($138.7M)
This 8-K covers: Material agreement (Item 1.01), Results of operations (Item 2.02), Reg FD disclosure (Item 7.01), Other events (Item 8.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.
Latest reported ALEC revenue for 2025-12-31 was $21.0M. Net income was -$142.9M. Revenue was down 79.1% from 2024-12-31 to 2025-12-31. ALEC currently screens at market cap $216.5M.
Not investment advice. The ALEC SEC hub lists recent forms. The stock page is the research view.
- Deal
- $138.7M
Why it matters
- Transaction value about $138.7M